Portfolio Update

RNS Number : 7761T

Intl. Biotechnology Trust PLC

11 June 2009

 



INTERNATIONAL BIOTECHNOLOGY TRUST PLC    

Portfolio update as at 31 May 2009                    

Total Net Assets	£89.2m
NAV per share	137.6p
Share Price	109.5p
Total value of unquoted investments	£21.8m
Total number of portfolio companies	63
Cash	2%
Cash committed and reserved to unquoted investments	13%
Portfolio companies with < 1 year of cash	17%

Top Ten Holdings

Company Name	% NAV	Market Value
Micromet	6.7	5,982,700
Celgene	4.6	4,094,482
Gilead Sciences	4.4	3,909,591
Amgen	4.3	3,833,176
Oxagen	4.2	3,780,406
Wright Medical	3.1	2,795,101
Alexion Pharmaceuticals	3.0	2,676,532
Halozyme Therapeutics	2.7	2,418,353
EV3	2.7	2,363,099
Celera	2.5	2,254,882
	-----------
Total	38.2	34,108,322

Geographical Allocation	%
United States	79
Europe	17
Australia	2
Cash	2
	-----------
Total	100

Quoted/Unquoted allocation	%
Quoted	73
Unquoted	25
Cash	2
	-----------
	100

BNP Paribas Secretarial Services Limited

Company Secretary

11 JUNE 2009

 

END

 

 

PFUBUGDLCDBGGCB